ims全球药物使用概览：展望2015.pdfVIP

The Global Use of Medicines: Outlook Through 2015 M y 2011 Report by the IMS Institute for Healthcare Informatics Introduction The future level of global spending on medicines has implications for healthcare systems and policy makers across developed and emerging economies. ey decision makers share the common goals of improving health outcomes, while controlling costs and expanding access to more of their citizens. In this context, spending on biopharmaceuticals, often considered a driver of cost growth, represents an important opportunity to achieve increased access, cost reductions and better outcomes. Past spending growth offers few clues to the level of growth to expect through 2015. Unprecedented dynamics are at play – including historically high levels IMS Institute for Healthcare Informatics 11 of patent expiry, rapid expansion of demand for medicines in the world’s fastest Waterview Boulevard growing economies, fewer new medicines reaching patients, and more Parsippany, NJ 07054 USA moderate uptake of those